
    
      This study will be a multi-center randomized controlled study. Eligible patients will be
      randomly assigned to receive a combination of G7 Acetabular system with CoC articulation and
      Taperloc Complete Microplasty stem or Exceed ABT Acetabular system with CoC articulation and
      Taperloc Complete Microplasty stem. Patient demographics, preoperative clinical outcomes,
      operative information, postoperative clinical outcome, radiographic assessment, incidence of
      squeaking, incidence of dislocation, implant survivorship and adverse events will be
      collected prospectively.
    
  